TM6SF2 and metabolic dysfunction-associated steatotic liver disease: However, the genes most robustly associated with NAFLD do not appear to contribute to increased cardiovascular risk in terms of CAD, and in fact TM6SF2 E167K is protective against CVD (IHD and ischemic stroke), and PNPLA3 I148M exerts no significant effect on CVD.